October 20, 2014: Tea could soon move beyond the kitchen to become a part of your medicine cabinet in the form a multi-nutritional capsule.
CSIR-Institute of Himalayan Bioresource Technology in Palampur, Himachal Pradesh, has developed technology to enable extraction of catechins with the help of water and green solvents and without deploying harmful chemicals. This technology will extract catechins from fresh shoots as well as other parts of the tea plant that are generally not part of the tea production process like flowers, fruits and mature shoots.
Baijnath Pharmaceuticals Pvt Ltd has signed an MoU with the institute for transfer of technology to produce of catechins and theaflavins. Multiple formulations of tea polyphenols are expected to be launched in the Indian market by next year. A source from the company said that they are anticipating revenues of Rs 10-15 crore per year.
Tea polyphenols, which are obtained from black tea, green tea and oolong tea, are known to be effective in preventing neurodegenerative diseases such as Alzheimer’s, Parkinson’s and also help combat cancer and heart ailments. These polyphenols are also useful in beverages, confectionery, cosmetics, food preservatives, etc. Tea catechins accounted for 72.5 per cent of the global polyphenols market in 2012. The market is expected to cross US$ 25 million in 2020.